LAVA-1207
lava therapeutics
['crpc', 'gu ', '$lvtx', 'lava therap']
$lvtx lava therapeutics announces initial data from the ongoing phase 1/2a clinical trial of lava-1207 in therapy refractory mcrpc at the 2023 asco gu symposium 
News and analysis of biomedical, biopharma, biotech, biosciences, pharmaceutical, and technology equities